Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a molecularly targeted drug
Key research findings Credit: KEN-ICHI ITO, SHINSHU UNIVERSITY Key research findings The multitargeted tyrosine kinase inhibitor (MKI), lenvatinib, is widely ...